News
Heron Therapeutics' Q1'25 earnings show Cinvanti leading, Zynrelef's 60% sales growth, raised EBITDA guidance & future ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback